Taking this into account, Guggenheim initiated its Compass Therapeutics Inc [CMPX] rating to a Buy in a research note published on February 24, 2025; the price target was $12. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid February with a ‘”an Overweight”‘ rating. D. Boral Capital began covering CMPX with “Buy” recommendation on December 23, 2024. Leerink Partners revised its rating on November 15, 2024. It rated CMPX as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of CMPX
On Tuesday, Compass Therapeutics Inc [NASDAQ:CMPX] saw its stock jump 17.89% to $2.24. Over the last five days, the stock has gained 3.46%. Compass Therapeutics Inc shares have risen nearly 54.48% since the year began. Nevertheless, the stocks have risen 13.13% over the past one year. While a 52-week high of $4.08 was reached on 02/11/25, a 52-week low of $0.76 was recorded on 04/01/25. SMA at 50 days reached $2.8100, while 200 days put it at $1.8000.
Levels Of Support And Resistance For CMPX Stock
The 24-hour chart illustrates a support level at 1.6300, which if violated will result in even more drops to 1.0100. On the upside, there is a resistance level at 2.5600. A further resistance level may holdings at 2.8700. The Relative Strength Index (RSI) on the 14-day chart is 44.45, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1900, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 31.84%. Stochastics %K at 25.71% indicates the stock is a holding.
How much short interest is there in Compass Therapeutics Inc?
A steep rise in short interest was recorded in Compass Therapeutics Inc stocks on 2025-03-14, growing by 1.07 million shares to a total of 4.61 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 3.53 million shares. There was a rise of 23.28%, which implies that there is a positive sentiment for the stock.
